Preliminary results of phase III study of mitomycin C versus estramustine in progressive metastatic prostate cancer refractory to hormonal therapy — results of EORTC GU group study no. 30865
Newling, D., Fossa, S., Tunn, U., Kurth, K.H., Pauw, M.de, Sylvester, R.Volume:
26
Language:
english
Journal:
European Journal of Cancer and Clinical Oncology
DOI:
10.1016/0277-5379(90)90318-N
Date:
February, 1990
File:
PDF, 130 KB
english, 1990